Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jason Morrow
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Physiology
Living Beings
Phenomena
Procedures
Sign-in to see full Profile
Network (preview)
82
Roberts, Jackson
27
Milne, Ginger
24
Montine, Thomas
21
Oates, John
21
Zackert, William
20
Yin, Huiyong
19
Awad, Joseph
16
Porter, Ned
14
Marnett, Lawrence
13
Musiek, Erik
13
DuBois, Raymond
13
Gao, Ling
10
Dey, Sudhansu
10
Burk, Raymond
9
Terry, Erin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jason Morrow (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kekatpure Vikram D; Boyle Jay O; Zhou Xi Kathy; Duffield-Lillico Anna J; Gross Neil D; Lee Nancy Y; Subbaramaiah Kotha; Morrow Jason D; Milne Ginger; Lippman Scott M; Dannenberg Andrew J
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.
Cancer prevention research (Philadelphia, Pa.) 2009;2(11):957-65.
-
2009: Zeiger Stephanie L H; Musiek Erik S; Zanoni Giuseppe; Vidari Giovanni; Morrow Jason D; Milne Ginger J; McLaughlin BethAnn
Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury.
Free radical biology & medicine 2009;47(10):1422-31.
-
2009: Liu Wei; Morrow Jason D; Yin Huiyong
Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method.
Free radical biology & medicine 2009;47(8):1101-7.
-
2009: Yin Huiyong; Liu Wei; Goleniewska Kasia; Porter Ned A; Morrow Jason D; Peebles R Stokes
Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation.
Free radical biology & medicine 2009;47(5):622-8.
-
2009: Redhage Leigh Anne; Shintani Ayumi; Haas David W; Emeagwali Nkiruka; Markovic Milica; Oboho Ikwo; Mwenya Christopher; Erdem Husamettin; Acosta Edward P; Morrow Jason D; Hulgan Todd
Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.
HIV clinical trials 2009;10(3):181-92.
-
2009: Yin Huiyong; Cox Brian E; Liu Wei; Porter Ned A; Morrow Jason D; Milne Ginger L
Identification of intact oxidation products of glycerophospholipids in vitro and in vivo using negative ion electrospray iontrap mass spectrometry.
Journal of mass spectrometry : JMS 2009;44(5):672-80.
-
2009: Du Liping; Yin Huiyong; Morrow Jason D; Strobel Henry W; Keeney Diane S
20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells.
Archives of biochemistry and biophysics 2009;484(1):80-6.
-
2009: Duffield-Lillico Anna J; Boyle Jay O; Zhou Xi Kathy; Ghosh Aradhana; Butala Geera S; Subbaramaiah Kotha; Newman Robert A; Morrow Jason D; Milne Ginger L; Dannenberg Andrew J
Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.
Cancer prevention research (Philadelphia, Pa.) 2009;2(4):322-9.
-
2009: Chung Cecilia P; Titova Dina; Oeser Annette; Randels Margaret; Avalos Ingrid; Milne Ginger L; Morrow Jason D; Stein C Michael
Oxidative stress in fibromyalgia and its relationship to symptoms.
Clinical rheumatology 2009;28(4):435-8.
-
2009: Adler David H; Phillips John A; Cogan Joy D; Iverson Tina M; Schnetz-Boutaud Nathalie; Stein Jeffrey A; Brenner David A; Milne Ginger L; Morrow Jason D; Boutaud Oliver; Oates John A
The enteropathy of prostaglandin deficiency.
Journal of gastroenterology 2009;44 Suppl 19():1-7.
-
2008: Musiek Erik S; Brooks Joshua D; Joo Myungsoo; Brunoldi Enrico; Porta Alessio; Zanoni Giuseppe; Vidari Giovanni; Blackwell Timothy S; Montine Thomas J; Milne Ginger L; McLaughlin BethAnn; Morrow Jason D
Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid.
The Journal of biological chemistry 2008;283(29):19927-35.
-
2008: Adler David H; Cogan Joy D; Phillips John A; Schnetz-Boutaud Nathalie; Milne Ginger L; Iverson Tina; Stein Jeffrey A; Brenner David A; Morrow Jason D; Boutaud Olivier; Oates John A
Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.
The Journal of clinical investigation 2008;118(6):2121-31.
-
2008: Dostalek Miroslav; Hardy Klarissa D; Milne Ginger L; Morrow Jason D; Chen Chi; Gonzalez Frank J; Gu Jun; Ding Xinxin; Johnson Delinda A; Johnson Jeffrey A; Martin Martha V; Guengerich F Peter
Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems.
The Journal of biological chemistry 2008;283(25):17147-57.
-
2008: Milne Ginger L; Yin Huiyong; Morrow Jason D
Human biochemistry of the isoprostane pathway.
The Journal of biological chemistry 2008;283(23):15533-7.
-
2008: Brooks Joshua D; Milne Ginger L; Yin Huiyong; Sanchez Stephanie C; Porter Ned A; Morrow Jason D
Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid.
The Journal of biological chemistry 2008;283(18):12043-55.
-
2008: Morrow J D
Why the United States still needs improved dietary supplement regulation and oversight.
Clinical pharmacology and therapeutics 2008;83(3):391-3.
-
2008: Kelly Peter J; Morrow Jason D; Ning MingMing; Koroshetz Walter; Lo Eng H; Terry Erin; Milne Ginger L; Hubbard Jane; Lee Hang; Stevenson Elizabeth; Lederer Megan; Furie Karen L
Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
Stroke; a journal of cerebral circulation 2008;39(1):100-4.
-
2007: Dostalek Miroslav; Brooks Joshua D; Hardy Klarissa D; Milne Ginger L; Moore Megan M; Sharma Sameer; Morrow Jason D; Guengerich F Peter
In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers.
Molecular pharmacology 2007;72(6):1419-24.
-
2007: Roberts L Jackson; Oates John A; Linton MacRae F; Fazio Sergio; Meador Beth P; Gross Myron D; Shyr Yu; Morrow Jason D
The relationship between dose of vitamin E and suppression of oxidative stress in humans.
Free radical biology & medicine 2007;43(10):1388-93.
-
2007: Brunoldi Enrico M; Zanoni Giuseppe; Vidari Giovanni; Sasi Soumya; Freeman Michael L; Milne Ginger L; Morrow Jason D
Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione.
Chemical research in toxicology 2007;20(10):1528-35.
-
2007: Yin Huiyong; Brooks Joshua D; Gao Ling; Porter Ned A; Morrow Jason D
Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo.
The Journal of biological chemistry 2007;282(41):29890-901.
-
2007: Musiek Erik S; McLaughlin Bethann; Morrow Jason D
Electrophilic cyclopentenone isoprostanes in neurodegeneration.
Journal of molecular neuroscience : MN 2007;33(1):80-6.
-
2007: Saraswathi Viswanathan; Gao Ling; Morrow Jason D; Chait Alan; Niswender Kevin D; Hasty Alyssa H
Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice.
The Journal of nutrition 2007;137(7):1776-82.
-
2007: Daikoku Takiko; Tranguch Susanne; Chakrabarty Anindita; Wang Dingzhi; Khabele Dineo; Orsulic Sandra; Morrow Jason D; Dubois Raymond N; Dey Sudhansu K
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer.
Cancer research 2007;67(11):5285-92.
-
2007: Hasty Alyssa H; Gruen Marnie L; Terry Erin S; Surmi Bonnie K; Atkinson Robin D; Gao Ling; Morrow Jason D
Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model.
The Journal of nutritional biochemistry 2007;18(2):127-33.
-
2007: Gao Ling; Wang Jiakun; Sekhar Konjeti R; Yin Huiyong; Yared Nicholas F; Schneider Scott N; Sasi Soumya; Dalton Timothy P; Anderson Mark E; Chan Jefferson Y; Morrow Jason D; Freeman Michael L
Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3.
The Journal of biological chemistry 2007;282(4):2529-37.
-
2007: Yin Huiyong; Gao Ling; Tai Hsin-Hsiung; Murphey Laine J; Porter Ned A; Morrow Jason D
Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.
The Journal of biological chemistry 2007;282(1):329-36.
-
2007: Avalos Ingrid; Chung Cecilia P; Oeser Annette; Milne Ginger L; Borntrager Holly; Morrow Jason D; Raggi Paolo; Solus Joseph; Stein C Michael
Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus.
Lupus 2007;16(12):981-6.
-
2007: Milne Ginger L; Yin Huiyong; Brooks Joshua D; Sanchez Stephanie; Jackson Roberts L; Morrow Jason D
Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
Methods in enzymology 2007;433():113-26.
-
2007: Avalos I; Chung C P; Oeser A; Milne G L; Morrow J D; Gebretsadik T; Shintani A; Yu C; Stein C M
Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms.
Lupus 2007;16(3):195-200.
-
2007: Milne Ginger L; Sanchez Stephanie C; Musiek Erik S; Morrow Jason D
Quantification of F2-isoprostanes as a biomarker of oxidative stress.
Nature protocols 2007;2(1):221-6.
-
2006: Luther James M; Gainer James V; Murphey Laine J; Yu Chang; Vaughan Douglas E; Morrow Jason D; Brown Nancy J
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
Hypertension 2006;48(6):1050-7.
-
2006: Takahashi Toshifumi; Morrow Jason D; Wang Haibin; Dey Sudhansu K
Cyclooxygenase-2-derived prostaglandin E(2) directs oocyte maturation by differentially influencing multiple signaling pathways.
The Journal of biological chemistry 2006;281(48):37117-29.
-
2006: Davis Todd A; Gao Ling; Yin Huiyong; Morrow Jason D; Porter Ned A
In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution.
Journal of the American Chemical Society 2006;128(46):14897-904.
-
2006: Johnson J Chad; Schmidt Carl R; Shrubsole Martha J; Billheimer D Dean; Joshi Prashant R; Morrow Jason D; Heslin Martin J; Washington M Kay; Ness Reid M; Zheng Wei; Schwartz David A; Coffey Robert J; Beauchamp R Daniel; Merchant Nipun B
Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(11):1358-65.
-
2006: Fowke Jay H; Morrow Jason D; Motley Saundra; Bostick Roberd M; Ness Reid M
Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake.
Carcinogenesis 2006;27(10):2096-102.
-
2006: Milne Ginger L; Morrow Jason D; Picklo Matthew J
Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal.
Neuroscience letters 2006;405(3):172-4.
-
2006: Qi Zhonghua; Cai Hui; Morrow Jason D; Breyer Matthew D
Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta.
Hypertension 2006;48(2):323-8.
-
2006: Hulgan Todd; Hughes Michael; Sun Xin; Smeaton Laura M; Terry Erin; Robbins Gregory K; Shafer Robert W; Clifford David B; McComsey Grace A; Canter Jeffery A; Morrow Jason D; Haas David W
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):450-4.
-
2006: Milne Ginger L; Morrow Jason D
Isoprostanes and related compounds: update 2006.
Antioxidants & redox signaling 2006;8(7-8):1379-84.
-
2006: Cotton Robert B; Hazinski Tom A; Morrow Jason D; Roberts L Jackson; Zeldin Darryl C; Lindstrom Daniel P; Lappalainen Urpo; Law Amy B; Steele Steven
Cimetidine does not prevent lung injury in newborn premature infants.
Pediatric research 2006;59(6):795-800.
-
2006: Musiek Erik S; Breeding Rebecca S; Milne Ginger L; Zanoni Giuseppe; Morrow Jason D; McLaughlin Bethann
Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.
Journal of neurochemistry 2006;97(5):1301-13.
-
2006: Gao Ling; Yin Huiyong; Milne Ginger L; Porter Ned A; Morrow Jason D
Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid.
The Journal of biological chemistry 2006;281(20):14092-9.
-
2006: Csiki Ildiko; Yanagisawa Kiyoshi; Haruki Nobuhiro; Nadaf Sorena; Morrow Jason D; Johnson David H; Carbone David P
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer.
Cancer research 2006;66(1):143-50.
-
2006: Babaev Vladimir R; Ding Lei; Reese Jeff; Morrow Jason D; Breyer Matthew D; Dey Sudhansu K; Fazio Sergio; Linton MacRae F
Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
Circulation 2006;113(1):108-17.
-
2006: Cotton Robert B; Sundell Håkan W; Zeldin Darryl C; Morrow Jason D; Roberts L Jackson; Hazinski Tom A; Law Amy B; Steele Steven
Inhaled nitric oxide attenuates hyperoxic lung injury in lambs.
Pediatric research 2006;59(1):142-6.
-
2006: Morrow Jason D
The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
Current pharmaceutical design 2006;12(8):895-902.
-
2005: Peebles R Stokes; Hashimoto Koichi; Sheller James R; Moore Martin L; Morrow Jason D; Ji Shaoquan; Elias Jack A; Goleniewska Kasia; O'neal Jamye; Mitchell Daphne B; Graham Barney S; Zhou Weisong
Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(12):8253-9.
-
2005: Milne Ginger L; Musiek Erik S; Morrow Jason D
F2-isoprostanes as markers of oxidative stress in vivo: an overview.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2005;10 Suppl 1():S10-23.
-
2005: Yin Huiyong; Porter Ned A; Morrow Jason D
Separation and identification of F2-isoprostane regioisomers and diastereomers by novel liquid chromatographic/mass spectrometric methods.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;827(1):157-64.
-
2005: Musiek Erik S; Yin Huiyong; Milne Ginger L; Morrow Jason D
Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
Lipids 2005;40(10):987-94.
-
2005: Musiek Erik S; Gao Ling; Milne Ginger L; Han Wei; Everhart M Brett; Wang Dingzhi; Backlund Michael G; DuBois Raymond N; Zanoni Giuseppe; Vidari Giovanni; Blackwell Timothy S; Morrow Jason D
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.
The Journal of biological chemistry 2005;280(42):35562-70.
-
2005: Csiki Ildiko; Morrow Jason D; Sandler Alan; Shyr Yu; Oates John; Williams Myles K; Dang Thao; Carbone David P; Johnson David H
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6634-40.
-
2005: Burleigh Michael E; Babaev Vladimir R; Yancey Patricia G; Major Amy S; McCaleb Jennifer L; Oates John A; Morrow Jason D; Fazio Sergio; Linton Macrae F
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice.
Journal of molecular and cellular cardiology 2005;39(3):443-52.
-
2005: Gross Neil D; Boyle Jay O; Morrow Jason D; Williams Myles K; Moskowitz Chaya S; Subbaramaiah Kotha; Dannenberg Andrew J; Duffield-Lillico Anna J
Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):6087-93.
-
2005: McAdam Brendan F; Byrne Daniel; Morrow Jason D; Oates John A
Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers.
Circulation 2005;112(7):1024-9.
-
2005: Komatsu Koga; Buchanan F Gregory; Katkuri Sharada; Morrow Jason D; Inoue Hiroyasu; Otaka Michiro; Watanabe Sumio; DuBois Raymond N
Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.
Gastroenterology 2005;129(2):577-90.
-
2005: Burleigh Michael E; Babaev Vladimir R; Patel Mayur B; Crews Brenda C; Remmel Rory P; Morrow Jason D; Oates John A; Marnett Lawrence J; Fazio Sergio; Linton Macrae F
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.
Biochemical pharmacology 2005;70(3):334-42.
-
2005: Yin Huiyong; Musiek Erik S; Gao Ling; Porter Ned A; Morrow Jason D
Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo.
The Journal of biological chemistry 2005;280(28):26600-11.
-
2005: Milne Ginger L; Gao Ling; Porta Alessio; Zanoni Giuseppe; Vidari Giovanni; Morrow Jason D
Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A(2t)-isoprostane in vivo.
The Journal of biological chemistry 2005;280(26):25178-84.
-
2005: Daikoku Takiko; Wang Dingzhi; Tranguch Susanne; Morrow Jason D; Orsulic Sandra; DuBois Raymond N; Dey Sudhansu K
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer.
Cancer research 2005;65(9):3735-44.
-
2005: Rouzer Carol A; Jacobs Aaron T; Nirodi Chetan S; Kingsley Philip J; Morrow Jason D; Marnett Lawrence J
RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-alpha secretion.
Journal of lipid research 2005;46(5):1027-37.
-
2005: Smith Layton Harris; Petrie Matthew S; Morrow Jason D; Oates John A; Vaughan Douglas E
The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells.
Journal of lipid research 2005;46(5):862-71.
-
2005: Musiek Erik S; Milne Ginger L; McLaughlin BethAnn; Morrow Jason D
Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.
Brain pathology (Zurich, Switzerland) 2005;15(2):149-58.
-
2005: Simmons Edith M; Langone Anthony; Sezer M Tugrul; Vella John P; Recupero Peter; Morrow Jason D; Ikizler T Alp; Himmelfarb Jonathan
Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.
Transplantation 2005;79(8):914-9.
-
2005: Morrow Jason D; Edeki Timi I; El Mouelhi Mohamed; Galinsky Raymond E; Kovelesky Rose; Noveck Robert J; Preuss Charles;
American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation.
Clinical pharmacology and therapeutics 2005;77(3):113-22.
-
2005: Canter Jeffrey A; Eshaghian Alex; Fessel Joshua; Summar Marshall L; Roberts L Jackson; Morrow Jason D; Sligh James E; Haines Jonathan L
Degree of heteroplasmy reflects oxidant damage in a large family with the mitochondrial DNA A8344G mutation.
Free radical biology & medicine 2005;38(5):678-83.
-
2005: Robbins Ivan M; Morrow Jason D; Christman Brian W
Oxidant stress but not thromboxane decreases with epoprostenol therapy.
Free radical biology & medicine 2005;38(5):568-74.
-
2005: Morrow Jason D
Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(2):279-86.
-
2005: Milne Ginger L; Musiek Erik S; Morrow Jason D
The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation.
Antioxidants & redox signaling 2005;7(1-2):210-20.
-
2005: Hashimoto Koichi; Sheller James R; Morrow Jason D; Collins Robert D; Goleniewska Kasia; O'Neal Jamye; Zhou Weisong; Ji Shaoquan; Mitchell Daphne B; Graham Barney S; Peebles R Stokes
Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(1):525-32.
-
2004: Buchanan F Gregory; Chang Woogki; Sheng Hongmiao; Shao Jinyi; Morrow Jason D; DuBois Raymond N
Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor.
Gastroenterology 2004;127(5):1391-400.
-
2004: Murphey Laine J; Williams Myles K; Sanchez Stephanie C; Byrne Loretta M; Csiki Ildiko; Oates John A; Johnson David H; Morrow Jason D
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Analytical biochemistry 2004;334(2):266-75.
-
2004: Hashimoto Koichi; Graham Barney S; Geraci Mark W; FitzGerald Garret A; Egan Karine; Zhou Weisong; Goleniewska Kasia; O'Neal Jamye F; Morrow Jason D; Durbin Russell K; Wright Peter F; Collins Robert D; Suzutani Tatsuo; Peebles R Stokes
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.
Journal of virology 2004;78(19):10303-9.
-
2004: Chen Xiwu; Moeckel Gilbert; Morrow Jason D; Cosgrove Dominic; Harris Raymond C; Fogo Agnes B; Zent Roy; Pozzi Ambra
Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury.
The American journal of pathology 2004;165(2):617-30.
-
2004: Rouzer Carol A; Kingsley Phillip J; Wang Haibin; Zhang Hao; Morrow Jason D; Dey Sudhansu K; Marnett Lawrence J
Cyclooxygenase-1-dependent prostaglandin synthesis modulates tumor necrosis factor-alpha secretion in lipopolysaccharide-challenged murine resident peritoneal macrophages.
The Journal of biological chemistry 2004;279(33):34256-68.
-
2004: Pozzi Ambra; Yan Xuexian; Macias-Perez Ines; Wei Shouzuo; Hata Aaron N; Breyer Richard M; Morrow Jason D; Capdevila Jorge H
Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.
The Journal of biological chemistry 2004;279(28):29797-804.
-
2004: Wang Xiaohong; Su Yan; Deb Kaushik; Raposo Monika; Morrow Jason D; Reese Jeff; Paria Bibhash C
Prostaglandin E2 is a product of induced prostaglandin-endoperoxide synthase 2 and microsomal-type prostaglandin E synthase at the implantation site of the hamster.
The Journal of biological chemistry 2004;279(29):30579-87.
-
2004: Wang Haibin; Ma Wen-ge; Tejada Lovella; Zhang Hao; Morrow Jason D; Das Sanjoy K; Dey Sudhansu K
Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup.
The Journal of biological chemistry 2004;279(11):10649-58.
-
2004: Nirodi Chaitanya S; Crews Brenda C; Kozak Kevin R; Morrow Jason D; Marnett Lawrence J
The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):1840-5.
-
2004: Milne Ginger L; Zanoni Giuseppe; Porta Alessio; Sasi Soumya; Vidari Giovanni; Musiek Erik S; Freeman Michael L; Morrow Jason D
The cyclopentenone product of lipid peroxidation, 15-A2t-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione.
Chemical research in toxicology 2004;17(1):17-25.
-
2004: Musiek Erik S; Cha Jin K; Yin Huiyong; Zackert William E; Terry Erin S; Porter Ned A; Montine Thomas J; Morrow Jason D
Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;799(1):95-102.
-
2004: Yin Huiyong; Morrow Jason D; Porter Ned A
Identification of a novel class of endoperoxides from arachidonate autoxidation.
The Journal of biological chemistry 2004;279(5):3766-76.
-
2003: Saha Debabrata; Sekhar Konjeti R; Cao Carolyn; Morrow Jason D; Choy Hak; Freeman Michael L
The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity.
Cancer research 2003;63(20):6920-7.
-
2003: Murphey Laine J; Morrow Jason D; Sawathiparnich Pairunyar; Williams Gordon H; Vaughan Douglas E; Brown Nancy J
Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives.
Free radical biology & medicine 2003;35(7):711-8.
-
2003: Fam Samuel S; Morrow Jason D
The isoprostanes: unique products of arachidonic acid oxidation-a review.
Current medicinal chemistry 2003;10(17):1723-40.
-
2003: Gao Ling; Zackert William E; Hasford Justin J; Danekis Michael E; Milne Ginger L; Remmert Catha; Reese Jeff; Yin Huiyong; Tai Hsin-Hsiung; Dey Sudhansu K; Porter Ned A; Morrow Jason D
Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase.
The Journal of biological chemistry 2003;278(31):28479-89.
-
2003: Yin Huiyong; Havrilla Christine M; Gao Ling; Morrow Jason D; Porter Ned A
Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. "Dioxetane" intermediate versus beta-fragmentation of peroxyl radicals.
The Journal of biological chemistry 2003;278(19):16720-5.
-
2003: Cutler N Shane; Graves-Deal Ramona; LaFleur Bonnie J; Gao Zhenqiang; Boman Bruce M; Whitehead Robert H; Terry Erin; Morrow Jason D; Coffey Robert J
Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.
Cancer research 2003;63(8):1748-51.
-
2003: Yang Li; Yamagata Noboru; Yadav Rajwardhan; Brandon Suzanne; Courtney Regina L; Morrow Jason D; Shyr Yu; Boothby Mark; Joyce Sebastian; Carbone David P; Breyer Richard M
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.
The Journal of clinical investigation 2003;111(5):727-35.
-
2003: Gupta Rajnish A; Tejada Lovella V; Tong Beverly J; Das Sanjoy K; Morrow Jason D; Dey Sudhansu K; DuBois Raymond N
Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
Cancer research 2003;63(5):906-11.
-
2003: Montine Thomas J; Montine Kathleen S; Reich Erin E; Terry Erin S; Porter Ned A; Morrow Jason D
Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes.
Biochemical pharmacology 2003;65(4):611-7.
-
2002: Morrow Jason D; Roberts L Jackson
The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
American journal of respiratory and critical care medicine 2002;166(12 Pt 2):S25-30.
-
2002: Kozak Kevin R; Crews Brenda C; Morrow Jason D; Wang Lee-Ho; Ma Y Henry; Weinander Rolf; Jakobsson Per-Johan; Marnett Lawrence J
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides.
The Journal of biological chemistry 2002;277(47):44877-85.
-
2002: Montine Thomas J; Milatovic Dejan; Gupta Ramesh C; Valyi-Nagy Tibor; Morrow Jason D; Breyer Richard M
Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent.
Journal of neurochemistry 2002;83(2):463-70.
-
2002: Ikizler T A; Morrow J D; Roberts L J; Evanson J A; Becker B; Hakim R M; Shyr Y; Himmelfarb J
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
Clinical nephrology 2002;58(3):190-7.
-
2002: Cox Brian; Murphey Laine J; Zackert William E; Chinery Rebecca; Graves-Deal Ramona; Boutaud Olivier; Oates John A; Coffey Robert J; Morrow Jason D
Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J(2), to glutathione.
Biochimica et biophysica acta 2002;1584(1):37-45.
-
2002: Montine Thomas J; Neely M Diana; Quinn Joseph F; Beal M Flint; Markesbery William R; Roberts L Jackson; Morrow Jason D
Lipid peroxidation in aging brain and Alzheimer's disease.
Free radical biology & medicine 2002;33(5):620-6.
-
2002: Fam Samuel S; Murphey Laine J; Terry Erin S; Zackert William E; Chen Yan; Gao Ling; Pandalai Saurabh; Milne Ginger L; Roberts L Jackson; Porter Ned A; Montine Thomas J; Morrow Jason D
Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid.
The Journal of biological chemistry 2002;277(39):36076-84.
-
2002: Montine Thomas J; Quinn Joseph F; Milatovic Dejan; Silbert Lisa C; Dang Theresa; Sanchez Stephanie; Terry Erin; Roberts L Jackson; Kaye Jeffrey A; Morrow Jason D
Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.
Annals of neurology 2002;52(2):175-9.
-
2002: Milatovic Dejan; Zhang Yueli; Olson Sandra J; Montine Kathleen S; Roberts L Jackson; Morrow Jason D; Montine Thomas J; Dermody Terence S; Valyi-Nagy Tibor
Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes.
Journal of neurovirology 2002;8(4):295-305.
-
2002: Qi Zhonghua; Hao Chuan-Ming; Langenbach Robert I; Breyer Richard M; Redha Reyadh; Morrow Jason D; Breyer Matthew D
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
The Journal of clinical investigation 2002;110(1):61-9.
-
2002: Yin Huiyong; Havrilla Christine M; Morrow Jason D; Porter Ned A
Formation of isoprostane bicyclic endoperoxides from the autoxidation of cholesteryl arachidonate.
Journal of the American Chemical Society 2002;124(26):7745-54.
-
2002: Smith Layton Harris; Boutaud Olivier; Breyer Matthew; Morrow Jason D; Oates John A; Vaughan Douglas E
Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(6):983-8.
-
2002: Roberts L Jackson; Morrow J D
Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
Cellular and molecular life sciences : CMLS 2002;59(5):808-20.
-
2002: Burleigh Michael E; Babaev Vladimir R; Oates John A; Harris Raymond C; Gautam Shiva; Riendeau Denis; Marnett Lawrence J; Morrow Jason D; Fazio Sergio; Linton MacRae F
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice.
Circulation 2002;105(15):1816-23.
-
2002: Peebles R Stokes; Hashimoto Koichi; Morrow Jason D; Dworski Ryszard; Collins Robert D; Hashimoto Yuko; Christman John W; Kang Kyung-Ho; Jarzecka Kasia; Furlong Jamye; Mitchell Daphne B; Talati Megha; Graham Barney S; Sheller James R
Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice.
American journal of respiratory and critical care medicine 2002;165(8):1154-60.
-
2002: May James M; Morrow Jason D; Burk Raymond F
Thioredoxin reductase reduces lipid hydroperoxides and spares alpha-tocopherol.
Biochemical and biophysical research communications 2002;292(1):45-9.
-
2002: Montine Kathleen S; Montine Thomas J; Morrow Jason D; Frei Balz; Milatovic Dejan; Eckenstein Felix; Quinn Joseph F
Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment.
Brain research 2002;930(1-2):75-82.
-
2002: Sasaki Diane M; Yuan Ying; Gikas Katherine; Kanai Kazuo; Taber Douglass; Morrow Jason D; Roberts L Jackson; Callewaert Denis M
Enzyme immunoassays for 15-F2T isoprostane-M, an urinary biomarker for oxidant stress.
Advances in experimental medicine and biology 2002;507():537-41.
-
2002: Reich Erin E; Montine Thomas J; Morrow Jason D
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid.
Advances in experimental medicine and biology 2002;507():519-24.
-
2002: Morrow Jason D; Roberts L Jackson
Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress.
Methods in molecular biology (Clifton, N.J.) 2002;186():57-66.
-
2001: Sofowora G; Dishy V; Xie H G; Imamura H; Nishimi Y; Morales C R; Morrow J D; Kim R B; Stein C M; Wood A J
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism.
Pharmacogenetics 2001;11(9):809-14.
-
2001: Morales C R; Terry E S; Zackert W E; Montine T J; Morrow J D
Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
Clinica chimica acta; international journal of clinical chemistry 2001;314(1-2):93-9.
-
2001: Robbins I M; Barst R J; Rubin L J; Gaine S P; Price P V; Morrow J D; Christman B W
Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.
Chest 2001;120(5):1639-44.
-
2001: Lekse J M; Xia L; Stark J; Morrow J D; May J M
Plant catechols prevent lipid peroxidation in human plasma and erythrocytes.
Molecular and cellular biochemistry 2001;226(1-2):89-95.
-
2001: May J M; Qu Z; Morrow J D
Mechanisms of ascorbic acid recycling in human erythrocytes.
Biochimica et biophysica acta 2001;1528(2-3):159-66.
-
2001: Kozak K R; Crews B C; Ray J L; Tai H H; Morrow J D; Marnett L J
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo.
The Journal of biological chemistry 2001;276(40):36993-8.
-
2001: Reich E E; Montine K S; Gross M D; Roberts L J; Swift L L; Morrow J D; Montine T J
Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(16):5993-9.
-
2001: VanderEnde D S; Morrow J D
Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde.
Journal of the American Academy of Dermatology 2001;45(1):62-7.
-
2001: Montine T J; Kaye J A; Montine K S; McFarland L; Morrow J D; Quinn J F
Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls.
Archives of pathology & laboratory medicine 2001;125(4):510-2.
-
2001: Dworski R; Roberts L J; Murray J J; Morrow J D; Hartert T V; Sheller J R
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(3):387-90.
-
2001: Reich E E; Markesbery W R; Roberts L J; Swift L L; Morrow J D; Montine T J
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.
The American journal of pathology 2001;158(1):293-7.
-
2001: Reich E E; Markesbery W R; Roberts L J; Swift L L; Morrow J D; Montine T J
Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.
Advances in experimental medicine and biology 2001;500():253-6.
-
2000: Shao J; Sheng H; Inoue H; Morrow J D; DuBois R N
Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells.
The Journal of biological chemistry 2000;275(43):33951-6.
-
2000: Morrow J D
The isoprostanes: their quantification as an index of oxidant stress status in vivo.
Drug metabolism reviews 2000;32(3-4):377-85.
-
2000: Reese J; Paria B C; Brown N; Zhao X; Morrow J D; Dey S K
Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(17):9759-64.
-
2000: May J M; Qu Z; Morrow J D; Cobb C E
Ascorbate-dependent protection of human erythrocytes against oxidant stress generated by extracellular diazobenzene sulfonate.
Biochemical pharmacology 2000;60(1):47-53.
-
2000: Marnett L J; Wright T L; Crews B C; Tannenbaum S R; Morrow J D
Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase.
The Journal of biological chemistry 2000;275(18):13427-30.
-
2000: Reich E E; Zackert W E; Brame C J; Chen Y; Roberts L J; Hachey D L; Montine T J; Morrow J D
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid.
Biochemistry 2000;39(9):2376-83.
-
2000: Roberts L J; Morrow J D
Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
Free radical biology & medicine 2000;28(4):505-13.
-
1999: Saha D; Datta P K; Sheng H; Morrow J D; Wada M; Moses H L; Beauchamp R D
Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.
Neoplasia (New York, N.Y.) 1999;1(6):508-17.
-
1999: Valyi-Nagy T; Sidell K R; Marnett L J; Roberts L J; Dermody T S; Morrow J D; Montine T J
Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis.
Journal of neuropathology and experimental neurology 1999;58(12):1269-75.
-
1999: Dworski R; Murray J J; Roberts L J; Oates J A; Morrow J D; Fisher L; Sheller J R
Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress.
American journal of respiratory and critical care medicine 1999;160(6):1947-51.
-
1999: Montine T J; Sidell K R; Crews B C; Markesbery W R; Marnett L J; Roberts L J; Morrow J D
Elevated CSF prostaglandin E2 levels in patients with probable AD.
Neurology 1999;53(7):1495-8.
-
1999: Daniel T O; Liu H; Morrow J D; Crews B C; Marnett L J
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Cancer research 1999;59(18):4574-7.
-
1999: Montine T J; Markesbery W R; Zackert W; Sanchez S C; Roberts L J; Morrow J D
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
The American journal of pathology 1999;155(3):863-8.
-
1999: Morrow J D; Oates J A; Roberts L J; Zackert W E; Mitchell T A; Lazarus G; Guzzo C
Increased formation of thromboxane in vivo in humans with mastocytosis.
The Journal of investigative dermatology 1999;113(1):93-7.
-
1999: Roberts L J; Salomon R G; Morrow J D; Brame C J
New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(10):1157-68.
-
1999: Williams C S; Goldman A P; Sheng H; Morrow J D; DuBois R N
Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
Neoplasia (New York, N.Y.) 1999;1(2):170-6.
-
1999: Lim H; Gupta R A; Ma W G; Paria B C; Moller D E; Morrow J D; DuBois R N; Trzaskos J M; Dey S K
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.
Genes & development 1999;13(12):1561-74.
-
1999: Chinery R; Coffey R J; Graves-Deal R; Kirkland S C; Sanchez S C; Zackert W E; Oates J A; Morrow J D
Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.
Cancer research 1999;59(11):2739-46.
-
1999: Brame C J; Salomon R G; Morrow J D; Roberts L J
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts.
The Journal of biological chemistry 1999;274(19):13139-46.
-
1999: Morrow J D; Zackert W E; Yang J P; Kurhts E H; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates J A; Roberts L J
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
Analytical biochemistry 1999;269(2):326-31.
-
1999: Chen Y; Morrow J D; Roberts L J
Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway.
The Journal of biological chemistry 1999;274(16):10863-8.
-
1999: Montine T J; Beal M F; Robertson D; Cudkowicz M E; Biaggioni I; O'Donnell H; Zackert W E; Roberts L J; Morrow J D
Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease.
Neurology 1999;52(5):1104-5.
-
1999: Morrow J D; Chen Y; Brame C J; Yang J; Sanchez S C; Xu J; Zackert W E; Awad J A; Roberts L J
The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation.
Drug metabolism reviews 1999;31(1):117-39.
-
1999: Montine T J; Beal M F; Cudkowicz M E; O'Donnell H; Margolin R A; McFarland L; Bachrach A F; Zackert W E; Roberts L J; Morrow J D
Increased CSF F2-isoprostane concentration in probable AD.
Neurology 1999;52(3):562-5.
-
1999: Chen Y; Zackert W E; Roberts L J; Morrow J D
Evidence for the formation of a novel cyclopentenone isoprostane, 15-A2t-isoprostane (8-iso-prostaglandin A2) in vivo.
Biochimica et biophysica acta 1999;1436(3):550-6.
-
1999: Morrow J D; Tapper A R; Zackert W E; Yang J; Sanchez S C; Montine T J; Roberts L J
Formation of novel isoprostane-like compounds from docosahexaenoic acid.
Advances in experimental medicine and biology 1999;469():343-7.
-
1999: Roberts L J; Brame C J; Chen Y; Morrow J D; Salomon R G
Formation of reactive products of the isoprostane pathway: isolevuglandins and cyclopentenone isoprostanes.
Advances in experimental medicine and biology 1999;469():335-41.
-
1999: Roberts L J; Brame C J; Chen Y; Morrow J D
Novel eicosanoids. Isoprostanes and related compounds.
Methods in molecular biology (Clifton, N.J.) 1999;120():257-85.
-
1999: Morrow J D; Roberts L J
Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.
Methods in enzymology 1999;300():3-12.
-
1998: Goldman A P; Williams C S; Sheng H; Lamps L W; Williams V P; Pairet M; Morrow J D; DuBois R N
Meloxicam inhibits the growth of colorectal cancer cells.
Carcinogenesis 1998;19(12):2195-9.
-
1998: Gainer J V; Morrow J D; Loveland A; King D J; Brown N J
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
The New England journal of medicine 1998;339(18):1285-92.
-
1998: Montine T J; Markesbery W R; Morrow J D; Roberts L J
Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
Annals of neurology 1998;44(3):410-3.
-
1998: Morrow J D; Scruggs J; Chen Y; Zackert W E; Roberts L J
Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo.
Journal of lipid research 1998;39(8):1589-93.
-
1998: Chinery R; Beauchamp R D; Shyr Y; Kirkland S C; Coffey R J; Morrow J D
Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.
Cancer research 1998;58(11):2323-7.
-
1998: Roberts L J; Montine T J; Markesbery W R; Tapper A R; Hardy P; Chemtob S; Dettbarn W D; Morrow J D
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.
The Journal of biological chemistry 1998;273(22):13605-12.
-
1998: Morrow J D; Roberts L J; Daniel V C; Awad J A; Mirochnitchenko O; Swift L L; Burk R F
Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.
Archives of biochemistry and biophysics 1998;353(1):160-71.
-
1998: Sheng H; Shao J; Morrow J D; Beauchamp R D; DuBois R N
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Cancer research 1998;58(2):362-6.
-
1997: Sheng G G; Shao J; Sheng H; Hooton E B; Isakson P C; Morrow J D; Coffey R J; DuBois R N; Beauchamp R D
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.
Gastroenterology 1997;113(6):1883-91.
-
1997: Roberts L J; Morrow J D
The generation and actions of isoprostanes.
Biochimica et biophysica acta 1997;1345(2):121-35.
-
1997: Morrow J D; Roberts L J
The isoprostanes: unique bioactive products of lipid peroxidation.
Progress in lipid research 1997;36(1):1-21.
-
1997: Coffey R J; Hawkey C J; Damstrup L; Graves-Deal R; Daniel V C; Dempsey P J; Chinery R; Kirkland S C; DuBois R N; Jetton T L; Morrow J D
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):657-62.
-
1997: Smith C J; Morrow J D; Roberts L J; Marnett L J
Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic cell line by treatment with the differentiating agent TPA.
Advances in experimental medicine and biology 1997;400A():99-106.
-
1996: Landino L M; Crews B C; Timmons M D; Morrow J D; Marnett L J
Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15069-74.
-
1996: Brown N J; Ryder D; Gainer J V; Morrow J D; Nadeau J
Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
The Journal of pharmacology and experimental therapeutics 1996;279(2):703-12.
-
1996: Morrow J D; Awad J A; Wu A; Zackert W E; Daniel V C; Roberts L J
Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo.
The Journal of biological chemistry 1996;271(38):23185-90.
-
1996: Roberts L J; Moore K P; Zackert W E; Oates J A; Morrow J D
Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans.
The Journal of biological chemistry 1996;271(34):20617-20.
-
1996: Stein C M; Tanner S B; Awad J A; Roberts L J; Morrow J D
Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.
Arthritis and rheumatism 1996;39(7):1146-50.
-
1996: Awad J A; Roberts L J; Burk R F; Morrow J D
Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage.
Gastroenterology clinics of North America 1996;25(2):409-27.
-
1996: May J M; Qu Z C; Morrow J D
Interaction of ascorbate and alpha-tocopherol in resealed human erythrocyte ghosts. Transmembrane electron transfer and protection from lipid peroxidation.
The Journal of biological chemistry 1996;271(18):10577-82.
-
1996: Morrow J D; Roberts L J
The isoprostanes. Current knowledge and directions for future research.
Biochemical pharmacology 1996;51(1):1-9.
-
1995: Awad J A; Morrow J D
Excretion of F2-isoprostanes in bile: a novel index of hepatic lipid peroxidation.
Hepatology (Baltimore, Md.) 1995;22(3):962-8.
-
1995: Burk R F; Hill K E; Awad J A; Morrow J D; Lyons P R
Liver and kidney necrosis in selenium-deficient rats depleted of glutathione.
Laboratory investigation; a journal of technical methods and pathology 1995;72(6):723-30.
-
1995: Morrow J D; Guzzo C; Lazarus G; Oates J A; Roberts L J
Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2.
The Journal of investigative dermatology 1995;104(6):937-40.
-
1995: Morrow J D; Frei B; Longmire A W; Gaziano J M; Lynch S M; Shyr Y; Strauss W E; Oates J A; Roberts L J
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.
The New England journal of medicine 1995;332(18):1198-203.
-
1995: Downard C D; Roberts L J; Morrow J D
Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo.
Clinical pharmacology and therapeutics 1995;57(4):441-5.
-
1995: Burk R F; Hill K E; Awad J A; Morrow J D; Kato T; Cockell K A; Lyons P R
Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and selenoprotein P.
Hepatology (Baltimore, Md.) 1995;21(2):561-9.
-
1995: Roberts L J; Morrow J D
The isoprostanes: novel markers of lipid peroxidation and potential mediators of oxidant injury.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():219-24.
-
1994: Morrow J D; Minton T A; Awad J A; Roberts L J
Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acid.
Archives of dermatology 1994;130(11):1408-12.
-
1994: Roberts L J; Morrow J D
Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.
Annals of the New York Academy of Sciences 1994;744():237-42.
-
1994: Longmire A W; Roberts L J; Morrow J D
Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor.
Prostaglandins 1994;48(4):247-56.
-
1994: Chaudhary A K; Nokubo M; Reddy G R; Yeola S N; Morrow J D; Blair I A; Marnett L J
Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver.
Science (New York, N.Y.) 1994;265(5178):1580-2.
-
1994: Stein C M; Longmire A W; Minton T A; Roberts L J; Pincus T; Morrow J D
Cyclosporine-induced alterations in renal function are not associated with lipid peroxidation.
Transplantation 1994;58(3):386-8.
-
1994: Awad J A; Morrow J D; Hill K E; Roberts L J; Burk R F
Detection and localization of lipid peroxidation in selenium- and vitamin E-deficient rats using F2-isoprostanes.
The Journal of nutrition 1994;124(6):810-6.
-
1994: Awad J A; Morrow J D; Roberts L J
Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation.
The Journal of allergy and clinical immunology 1994;93(5):817-24.
-
1994: Daniel V C; Minton T A; Brown N J; Nadeau J H; Morrow J D
Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical applications 1994;653(2):117-22.
-
1994: Longmire A W; Swift L L; Roberts L J; Awad J A; Burk R F; Morrow J D
Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes.
Biochemical pharmacology 1994;47(7):1173-7.
-
1994: Lynch S M; Morrow J D; Roberts L J; Frei B
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.
The Journal of clinical investigation 1994;93(3):998-1004.
-
1994: Morrow J D; Minton T A; Mukundan C R; Campbell M D; Zackert W E; Daniel V C; Badr K F; Blair I A; Roberts L J
Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.
The Journal of biological chemistry 1994;269(6):4317-26.
-
1994: Morrow J D; Minton T A; Badr K F; Roberts L J
Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.
Biochimica et biophysica acta 1994;1210(2):244-8.
-
1994: Morrow J D; Roberts L J
Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism.
Methods in enzymology 1994;233():163-74.
-
1993: Awad J A; Morrow J D; Roberts L J
Simplification of the mass spectrometric assay for the major urinary metabolite of prostaglandin D2.
Journal of chromatography 1993;617(1):124-8.
-
1993: Morrow J D; Moore K P; Awad J A; Ravenscraft M D; Marini G; Badr K F; Williams R; Roberts L J
Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome.
Journal of lipid mediators 1993;6(1-3):417-20.
-
1993: Morrow J D; Minton T A
Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry.
Journal of chromatography 1993;612(2):179-85.
-
1993: Awad J A; Morrow J D; Takahashi K; Roberts L J
Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma.
The Journal of biological chemistry 1993;268(6):4161-9.
-
1993: Kang K H; Morrow J D; Roberts L J; Newman J H; Banerjee M
Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung.
Journal of applied physiology (Bethesda, Md. : 1985) 1993;74(1):460-5.
-
1992: Morrow J D; Awad J A; Kato T; Takahashi K; Badr K F; Roberts L J; Burk R F
Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation.
The Journal of clinical investigation 1992;90(6):2502-7.
-
1992: Morrow J D; Awad J A; Boss H J; Blair I A; Roberts L J
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10721-5.
-
1992: Banerjee M; Kang K H; Morrow J D; Roberts L J; Newman J H
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ.
The American journal of physiology 1992;263(3 Pt 2):H660-3.
-
1992: Morrow J D; Minton T A; Roberts L J
The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist.
Prostaglandins 1992;44(2):155-63.
-
1992: Takahashi K; Nammour T M; Fukunaga M; Ebert J; Morrow J D; Roberts L J; Hoover R L; Badr K F
Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
The Journal of clinical investigation 1992;90(1):136-41.
-
1992: Morrow J D; Awad J A; Oates J A; Roberts L J
Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
The Journal of investigative dermatology 1992;98(5):812-5.
-
1991: Morrow J D; Margolies G R; Rowland J; Roberts L J
Evidence that histamine is the causative toxin of scombroid-fish poisoning.
The New England journal of medicine 1991;324(11):716-20.
-
1991: Morrow J D; Prakash C; Awad J A; Duckworth T A; Zackert W E; Blair I A; Oates J A; Roberts L J
Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay.
Analytical biochemistry 1991;193(1):142-8.
-
1991: Morrow J D; Roberts L J
Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress.
Free radical biology & medicine 1991;10(3-4):195-200.
-
1991: Sladek K; Sheller J R; FitzGerald G A; Morrow J D; Roberts L J
Formation of PGD2 after allergen inhalation in atopic asthmatics.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():433-6.
-
1991: Morrow J D; Hill K E; Burk R F; Nammour T M; Badr K F; Roberts L J
Formation of unique biologically active prostaglandins in vivo by a non-cyclooxygenase free radical catalyzed mechanism.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():125-8.
-
1991: Morrow J D; Prakash C; Duckworth T A; Zackert W E; Blair I A; Oates J A; Roberts L J
A stable isotope dilution mass spectrometric assay for the major urinary metabolite of PGD2.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():315-8.
-
1990: Morrow J D; Hill K E; Burk R F; Nammour T M; Badr K F; Roberts L J
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(23):9383-7.
-
1990: Morrow J D; Harris T M; Roberts L J
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids.
Analytical biochemistry 1990;184(1):1-10.
-
1989: Morrow J D; Parsons W G; Roberts L J
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
Prostaglandins 1989;38(2):263-74.
Sign-in to see more
